C-Reactive Protein in Bladder Cancer: Where Do We Stand?

Nature Reviews Urology - United Kingdom
doi 10.1038/nrurol.2011.145-c1
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Targeting Angiogenesis in Cancer Treatments: Where Do We Stand?

Journal of Pharmacy and Pharmaceutical Sciences
MedicinePharmacologyPharmaceutical Science
2016English

Blockchain in Academia: Where Do We Stand and Where Do We Go?

2020English

Systemic Chemotherapy in Gastric Cancer: Where Do We Stand Today?

Oncologist
Cancer ResearchMedicineOncology
1998English

Transitional Cell Carcinoma of the Bladder in Pediatric Patients: Where Do We Stand?

Urologia Colombiana
Urology
2020English

High Energy Neutrino Astronomy: Where Do We Stand, Where Do We Go?

Physics of Particles and Nuclei
High Energy PhysicsNuclear
2018English

Schistosomiasis Vaccines: Where Do We Stand?

Parasites and Vectors
ParasitologyInfectious Diseases
2016English

Where Do We Stand After Coty?

Competition Law Journal
2018English

Quantum Computers: Where Do We Stand?

Europhysics News
AstronomyPhysics
2005English

Second-Line Treatment of Advanced Gastric Cancer: Where Do We Stand?

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy